Skip to Content

A questionnaire to improve heart failure treatments was one of the first tools accepted into an FDA program that highlights resources for medical device development.

The Minnesota Living with Heart Failure Questionnaire, a 21-question survey that determines how treatment for heart failure is affecting an individual patient’s life, received FDA Medical Device Development Tools (MDDT) status in March. This qualification means the FDA has reviewed and affirmed evidence that the questionnaire is a reliable resource for device makers to use in gauging how new heart failure treatments affect patients’ quality of life.

Read the full story in the U's Inquiry blog.